WW ANNOUNCES STUDY RESULTS SHOWING CLINICALLY SIGNIFICANT IMPROVEMENTS FOR PEOPLE LIVING WITH DIABETES ON CUSTOMIZED PROGRAM

Positive Clinical Trial Results Revealed at ADA 82nd Scientific Sessions NEW YORK, June 4, 2022 /PRNewswire/ — WW International, Inc. (NASDAQ: WW) (“WeightWatchers,” “WW,” or “the Company”) announced today, at the American Diabetes Association (ADA) 82nd Scientific Sessions, positive…

Leave a Reply

Your email address will not be published.